| |
A | B - D | E - G | H - L | M - N | 0 - P | R - T | U - Z
Portfolio as at February 29, 2008
| Company |
Location |
Investment |
A |
ActivBiotics (Ontario) Inc.
|
Mississauga, ON |
CMDF $6,500,000 |
Engaged in the development and commercialization of antibacterials for the treatment of acute and chronic disease.
|
|
|
Adnavance Technologies
|
Saskatoon, SK |
CMDF $2,806,000 |
Developing metallic DNA ("M-DNA") for application in large life sciences and nanotechnology markets
|
|
|
AEgera Therapeutics
|
Montreal, PQ |
CMDF $5,608,000 |
Novel therapeutics for degenerative neurological diseases
|
|
|
Agrisoma Biosciences
|
Burnaby, BC |
CMDF $2,660,000 |
Developing and commercializing chromosome-based gene transfer technology to enable the discovery and development of high vale traits in crops like grains with enhanced nutrition; and enable the production of proteins in plant-based systems
|
|
|
Ambit Biosciences Canada
|
Toronto, On |
CMDF $9,060,000 |
Developing novel drugs for the treatment of stroke and other central nervous system disorders and for the treatment of various cancers
|
|
C |
Cytochroma
|
Markham, ON |
CMDF $7,890,000 |
Small molecule drug discovery & development company
|
|
D |
DC Bio
|
Halifax, NS |
CMDF $3,610,000 |
Developing RNA-based ex vivo dendritic cell vaccine technology for application to cancer and diseases associated with chronic viral infections
|
|
G |
Gemin X Biotechnologies
|
Montreal, PQ |
CMDF $10,700,000 |
Therapeutics to stimulate cancer cell death
|
|
I |
Inimex Pharmaceuticals
|
Vancouver, BC |
CMDF $3,140,000 |
Development of new medicines that utilize the innate immune response to prevent or treat human disease
|
|
L |
LifeMark Health Limited
|
Calgary, AB |
CMDF $320,300 |
One of Canada’s largest providers of physiotherapy, rehabilitation and occupational health services.
|
|
|
Luminex Corporation
Nasdaq: LMNX |
Austin, TX |
CMDF $2,499,768 |
Develops, manufactures and markets proprietary biological testing technologies.
|
|
M |
MedInnova Partners
|
Toronto, ON |
CMDF $20,000,000 |
Protection of early-stage technologies predominantly in the Atlantic region
|
|
|
MedTech Partners
|
Ottawa, ON |
CMDF $13,000,000 |
Incubator for early-stage technologies
|
|
|
MethylGene
TSX-MYG |
Montreal, PQ |
CMDF $2,900,000 |
Cancer therapeutics based on genomics technology
|
|
N |
Networc Health
|
Calgary, AB |
CMDF $1,284,000 |
Provider of health-related services across Canada
|
|
|
Neuromed Pharmaceuticals
|
Vancouver, BC |
CMDF $6,507,000 |
Discovery and development of new and improved pain therapies.
|
|
|
NPS Pharmaceuticals
Nasdaq: NPSP |
Bedminister, NJ |
CMDF $105,000 |
Developing speciality therapeutics for gastrointestinal and endocrine disorders with high unmet medical need.
|
|
|
NYSA Membrane Technologies Inc.
|
Burlington, ON |
CMDF $5,515,000 |
Developing a membrane-based platform technology that improves the safety of the separation processes required to purify proteins and other compounds.
|
|
P |
Painceptor Pharma
|
Ottawa, ON |
CMDF $4,525,000 |
Development of new peripheral nervous system active drugs for the treatment of pain
|
|
|
PharmAthene
Amex: PIP |
Toronto, ON |
CMDF $5,190,000 |
Develops a comprehensive array of countermeasures to bioterrorism
|
|
|
Praxim Corporation
|
La Trouche, FR |
CMDF $7,495,000 |
Developing a computer assisted orthopedic surgery (CAOS) system to assit surgeons during orthopedic procedures
|
|
|
Protiva Biotherapeutics
|
Burnaby, BC |
CMDF $3,220,000 |
Development of a systemic; non-viral gene-delivery platform
|
|
R |
Resonant Medical
|
Montreal, PQ |
CMDF $500,000 |
Researches, develops, integrates, and markets medical technology hardware and software solutions
|
|
|
Resonant Medical Technologies
|
Toronto, ON |
CMDF $7,500,000 |
Researches, develops, integrates, and markets medical technology hardware and software solutions
|
|
S |
Spectral Diagnostics
TSX : SDI |
Toronto, ON |
CMDF $4,850,000 |
Development and commercialization of innovative rapid diagnostics
|
|
|
Star Bio Investments
|
Saskatoon, SK |
CMDF $3,960,000 |
Development of therapies for hormone-dependent cancers and other serious disorders
|
|
|
Systems Xcellence
TSX : SXC |
Milton, ON |
CMDF $1,750,000 |
Computer software for health services businesses
|
|
T |
Targanta Therapeutics
Nasdaq: TARG |
Montreal, PQ |
CMDF $8,130,000 |
Drug discovery of new class of antibiotics
|
|
|
Transition Therapeutics
TSX : TTH, Nasdaq: TTHI |
Toronto, ON |
CMDF $1,670,000 |
Biopharmaceuticals for the development of regenerative therapies for the treatment of diabetes; MS and stroke
|
|
|
Trillium Therapeutics
|
Toronto, ON |
CMDF $3,270,000 |
Development of therapies that restore balance to the immune system
|
|
|
Twinstrand Therapeutics
|
Burnaby, BC |
CMDF $4,430,000 |
Development of recombinant therapeutics for the treatment of human diseases
|
|
V |
ViOptix
|
Toronto, ON |
CMDF $10,180,000 |
Developer of non-invasive medical devices to measure oxygen levels in tissue; for use in surgery; peripheral vascular disease; and wound management.
|
|
|
Viron Therapeutics
|
London, ON |
CMDF $7,004,000 |
Developer of non-invasive medical devices to measure oxygen levels in tissue; for use in surgery; peripheral vascular disease; and wound management.
|
|
W |
WV CMDF Queen’s Scientific Breakthrough Fund
|
Kingston, ON |
CMDF $1,380,000 |
Technologies developed at Queen's University
|
|
|
